| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Long.term potentiation |
5 genes: GNAQ, PPP3CA, PPP3CC, MAPK1, RAP1A
|
0.0002904 |
| Adherens junction |
5 genes: CTNND1, MAPK1, TGFBR2, TJP1, ACTN1
|
0.0003533 |
| B cell receptor signaling pathway |
5 genes: AKT3, FOS, PPP3CA, PPP3CC, MAPK1
|
0.0004006 |
| MAPK signaling pathway |
9 genes: AKT3, FGF9, FOS, PPP3CA, PPP3CC, MAPK1, TAOK1, RAP1A, TGFBR2
|
0.0004139 |
| Osteoclast differentiation |
6 genes: AKT3, FOS, PPP3CA, PPP3CC, MAPK1, TGFBR2
|
0.0007033 |
| Axon guidance |
6 genes: SEMA3C, NTNG1, PPP3CA, PPP3CC, MAPK1, RGS3
|
0.0007629 |
| T cell receptor signaling pathway |
5 genes: AKT3, FOS, PPP3CA, PPP3CC, MAPK1
|
0.002078 |
| Calcium signaling pathway |
6 genes: ADCY2, GNAQ, ATP2B4, PPP3CA, PPP3CC, SLC8A2
|
0.003649 |
| VEGF signaling pathway |
4 genes: AKT3, PPP3CA, PPP3CC, MAPK1
|
0.003692 |
| Tight junction |
5 genes: AKT3, AMOTL1, PPP2R2C, TJP1, ACTN1
|
0.00508 |
| Gap junction |
4 genes: ADCY2, GNAQ, MAPK1, TJP1
|
0.006725 |
| Pancreatic secretion |
4 genes: ADCY2, GNAQ, ATP2B4, RAP1A
|
0.01002 |
| Oocyte meiosis |
4 genes: ADCY2, PPP3CA, PPP3CC, MAPK1
|
0.01508 |
| Vascular smooth muscle contraction |
4 genes: ADCY2, GNAQ, MAPK1, CALD1
|
0.01598 |
| Ubiquitin mediated proteolysis |
4 genes: UBE2E2, UBE2H, HERC1, KLHL13
|
0.02876 |
| Regulation of actin cytoskeleton |
5 genes: ABI2, FGF9, APC, MAPK1, ACTN1
|
0.03323 |
| Progesterone.mediated oocyte maturation |
3 genes: AKT3, ADCY2, MAPK1
|
0.03586 |
| Ether lipid metabolism |
2 genes: PAFAH1B1, PAFAH1B2
|
0.03588 |
| Wnt signaling pathway |
4 genes: CSNK1A1, APC, PPP3CA, PPP3CC
|
0.03728 |
| Apoptosis |
3 genes: AKT3, PPP3CA, PPP3CC
|
0.03797 |
| Salivary secretion |
3 genes: ADCY2, GNAQ, ATP2B4
|
0.03797 |
| Hippo signaling pathway |
4 genes: PPP2R2C, GLI2, TGFBR2, APC
|
0.03961 |